Search Results - "Naffouje, Samer"

ASO Author Reflections: Is Minimally Invasive Ivor–Lewis the Future of Esophagectomy? by Naffouje, Samer A.

Get full text

ASO Author Reflections: Neoadjuvant Immunotherapy for Merkel Cell Carcinoma with Clinically Detected Regional Lymph Node Metastasis? by Chang, Jenny H., Woo, Kimberly P., Naffouje, Samer A.

Get full text

Outcomes of Open Versus Minimally Invasive Ivor-Lewis Esophagectomy for Cancer: A Propensity-Score Matched Analysis of NSQIP Database by Naffouje, Samer A., Salloum, Rony H., Khalaf, Zaynab, Salti, George I.

“…Introduction We conducted this analysis to compare the outcomes of open transthoracic esophagectomy (OTTE) and minimally invasive transthoracic esophagectomy…”
Get full text

Feasibility of hand-assisted laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancy by Salti, George I., Naffouje, Samer A.

“…Background In light of the modern surgical trend towards minimally invasive surgery, we aim to assess the feasibility of hand-assisted laparoscopic (HAL)…”
Get full text

ASO Visual Abstract: Surgical Management of the Axilla in HR+/HER2-Breast Cancer in the Z1071 Era: A Propensity-Score Matched Analysis of the National Cancer Database by Barker, Vayda R., Naffouje, Samer A., Mallory, Melissa A., Hoover, Susan A., Laronga, Christine

Get full text

Impact of Enhanced Recovery After Surgery on Postoperative Outcomes for Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy by White, Bradley, Dahdaleh, Fadi, Naffouje, Samer A., Kothari, Neerav, Berg, Jessica, Wiemann, Wendy, Salti, George I.

“…Background Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) have been associated with significant morbidity and increased…”
Get full text

Surgical Management of the Axilla in HR+/HER2– Breast Cancer in the Z1071 Era: A Propensity Score-Matched Analysis of the National Cancer Database by Barker, Vayda R., Naffouje, Samer A., Mallory, Melissa A., Hoover, Susan A., Laronga, Christine

“…Background Axillary management varies between sentinel lymph node biopsy (SLNB) and axillary lymph node dissection (ALND) for patients with clinical N1 (cN1),…”
Get full text

A Practical Strategy to Reduce Surgical Overtreatment of Intraductal Papillary Mucinous Neoplasms of the Pancreas by Chang, Jenny H, Wehrle, Chase, Hossain, Mir Shanaz, Woo, Kimberly, Stackhouse, Kathryn, Augustin, Toms, Simon, Robert, Joyce, Daniel, Fleming, Jason B, Naffouje, Samer A

Get full text

The Role of Neoadjuvant Immunotherapy in the Management of Merkel Cell Carcinoma with Clinically Detected Regional Lymph Node Metastasis by Chang, Jenny H., Remulla, Daphne, Wehrle, Chase, Woo, Kimberly P., Dahdaleh, Fadi S., Joyce, Daniel, Naffouje, Samer A.

“…Background Immunotherapy is emerging as a promising option for certain locally advanced and metastatic cutaneous malignancies. However, the role of neoadjuvant…”
Get full text

Impact of Neoadjuvant Systemic Therapy on Pancreatic Fistula Rates Following Pancreatectomy: a Population-Based Propensity-Matched Analysis by Dahdaleh, Fadi S., Naffouje, Samer A., Hanna, Mark H., Salti, George I.

“…Introduction Postoperative pancreatic fistula (POPF) drives morbidity and mortality following pancreatectomy. Use of neoadjuvant chemotherapy (NAC) has…”
Get full text

Neoadjuvant systemic therapy in geriatric breast cancer patients: a National Cancer Database (NCDB) analysis by Brown, Lauren, Naffouje, Samer A., Sam, Christine, Laronga, Christine, Catherine Lee, M.

“…Purpose Neoadjuvant systemic therapy (NAST) can be an effective treatment option for patients with HER2 + or triple negative breast cancer (TNBC). However, its…”
Get full text

Adjuvant Chemotherapy Associated with Survival Benefit Following Neoadjuvant Chemotherapy and Pancreatectomy for Pancreatic Ductal Adenocarcinoma: A Population-Based Cohort Study by Kamarajah, Sivesh K., White, Steven A., Naffouje, Samer A., Salti, George I, Dahdaleh, Fadi

“…Background Data supporting the routine use of adjuvant chemotherapy (AC) compared with no AC (noAC) following neoadjuvant chemotherapy (NAC) and resection for…”
Get full text

Comparing oncologic and surgical outcomes of robotic and laparoscopic distal pancreatectomy: a propensity-matched analysis by Chang, Jenny H., Wehrle, Chase, Woo, Kimberly, Naples, Robert, Stackhouse, Kathryn A., Dahdaleh, Fadi, Joyce, Daniel, Simon, Robert, Augustin, Toms, Walsh, R. Matthew, Naffouje, Samer A.

“…Background The frequency of minimally invasive distal pancreatectomy is gradually exceeding that of the open approach. Our study aims to compare short-term…”
Get full text

ASO Visual Abstract: The Role of Neoadjuvant Immunotherapy in the Management of Merkel Cell Carcinoma with Clinically Detected Regional Lymph Node Metastasis by Chang, Jenny H., Remulla, Daphne, Wehrle, Chase, Woo, Kimberly P., Dahdaleh, Fadi S., Joyce, Daniel, Naffouje, Samer A.

Get full text

Surgical Approach does not Affect Return to Intended Oncologic Therapy Following Pancreaticoduodenectomy for Pancreatic Adenocarcinoma: A Propensity-Matched Study by Naffouje, Samer A., Kamarajah, Sivesh K., Denbo, Jason W., Salti, George I., Dahdaleh, Fadi S.

“…Background The effect of minimally invasive pancreaticoduodenectomy (MIPD), including laparoscopic and robotic pancreaticoduodenectomy (LPD and RPD,…”
Get full text

Surgical Management of Axilla of Triple-Negative Breast Cancer in the Z1071 Era: A Propensity Score-Matched Analysis of the National Cancer Database by Naffouje, Samer A., Barker, Vayda, Lee, M. Catherine, Hoover, Susan J., Laronga, Christine

“…Background The role of sentinel lymph node biopsy (SLNB) in triple-negative breast cancer (TNBC) patients who present with clinical N1 (cN1) disease and…”
Get full text

Return to intended oncologic therapy after colectomy for stage III colon adenocarcinoma: Does surgical approach matter? by Pointer, Jr, David T, Felder, Seth I, Powers, Benjamin D, Dessureault, Sophie, Sanchez, Julian A, Imanirad, Iman, Sahin, Ibrahim, Xie, Hao, Naffouje, Samer A

“…Return to intended oncologic treatment (RIOT) is an important paradigm for surgically resected cancers requiring multimodal treatment. Benefits of minimally…”
Get full text

Surgical Management of the Axilla of HER2+ Breast Cancer in the Z1071 Era: A Propensity-Score-Matched Analysis of the NCDB by Naffouje, Samer A., Sabesan, Arvind, Hoover, Susan J., Lee, Marie C., Laronga, Christine

“…Introduction We aim to analyze survival outcomes for sentinel lymph node biopsy (SLNB) versus axillary lymph node dissection (ALND) in human epidermal growth…”
Get full text

Outcomes of 350 Robotic-assisted Esophagectomies at a High-volume Cancer Center: A Contemporary Propensity-score Matched Analysis by Pointer, David T, Saeed, Sabrina, Naffouje, Samer A, Mehta, Rutika, Hoffe, Sarah E, Dineen, Sean P, Fleming, Jason B, Fontaine, Jacques P, Pimiento, Jose M

“…OBJECTIVE:To evaluate perioperative and oncologic outcomes in our RAMIE cohort and compare outcomes with contemporary OE controls. SUMMARY OF BACKGROUND…”
Get full text

Neoadjuvant rectal score is prognostic for survival: A population‐based propensity‐matched analysis by Naffouje, Samer A., Manguso, Nicholas, Imanirad, Iman, Sahin, Ibrahim H., Xie, Hao, Hoffe, Sarah, Frakes, Jessica, Sanchez, Julian, Dessureault, Sophie, Felder, Seth

“…Introduction Neoadjuvant rectal (NAR) score may serve as a surrogate short‐term endpoint for overall survival (OS) in clinical trials. This study aims to test…”
Get full text